FDA Drug Recalls
1,463 recalls · Class I, newest first
Class I · High risk Terminated Aug 24, 2015
Reason Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.
Class I · High risk Terminated Aug 24, 2015
Reason Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.
Class I · High risk Terminated Aug 24, 2015
Reason Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.
Class I · High risk Terminated Aug 24, 2015
Reason Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.
Class I · High risk Terminated Aug 24, 2015
Reason Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.
Class I · High risk Terminated Aug 24, 2015
Reason Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.
Class I · High risk Terminated Aug 21, 2015
Reason Subpotent Drug
Class I · High risk Terminated Aug 21, 2015
Reason Subpotent Drug
Class I · High risk Terminated Aug 21, 2015
Reason Subpotent Drug
Class I · High risk Terminated Aug 21, 2015
Reason Subpotent Drug
Class I · High risk Terminated Aug 21, 2015
Reason Subpotent Drug
Class I · High risk Terminated Aug 21, 2015
Reason Subpotent Drug
Class I · High risk Terminated Aug 21, 2015
Reason Subpotent Drug
Class I · High risk Terminated Aug 17, 2015
Reason Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.
Class I · High risk Terminated Aug 17, 2015
Reason Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.
Class I · High risk Terminated Aug 6, 2015
Reason Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.
Class I · High risk Terminated Aug 6, 2015
Reason Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.
Class I · High risk Terminated Jul 24, 2015
Reason Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution
Class I · High risk Terminated Jul 17, 2015
Reason Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.
Class I · High risk Terminated Jul 17, 2015
Reason Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.
Class I · High risk Terminated Jul 17, 2015
Reason Subpotent Drug: confirmed subpotency in one lot of this product that was packaged and stored in syringes.
Class I · High risk Terminated Jun 12, 2015
Reason Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared diclofenac, a prescription non-steroidal anti-inflammatory drug, and…
Class I · High risk Terminated Jun 3, 2015
Reason Marketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.
Class I · High risk Terminated Jun 3, 2015
Reason Marketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.
Class I · High risk Terminated May 22, 2015
Reason Sub-potent Drug; firm's analysis revealed subpotent result for morphine sulfate assay.